Method for identifying active anti apoptosis compounds

Details Method for identifying active anti apoptosis compounds Method for identifying active anti apoptosis compounds

2006-03-07

2006-03-07

Chan, Christina (Department: 1644)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S007210

Reexamination Certificate

active

07008773

ABSTRACT:
The invention relates to a method for identifying substances with antiapoptotic activity, wherei) cells which express both IAP and the integrin αvβ3are cultured,ii) the cells are caused to produce an apoptosis-inducing substance, and/or a substance or substances which induces/induce apoptosis is/are added,iii) the test substance is added, andiv) the apoptosis rate is measured, and to the substances which can be identified with the method.

REFERENCES:
patent: 6191269 (2001-02-01), Pollock et al.
patent: 6562797 (2003-05-01), Dixit et al.
patent: 903 149 (1999-03-01), None
patent: WO 99/40940 (1999-08-01), None
Kuntz, Structure-based strategies for drug design and discovery. Science. 1992 257(5073):1078-1082.
“Thrombospondin Modulates αvβ3Function Through Integrin-Associated Protein”, Gao et al., The Journal of Cell Biology, vol. 135, No. 2, Oct. 1996, pp. 533-544.
“CD47 Ligation Induces Caspase-Independent Cell Death in Chronic Lymphocytic Leukemia”, Mateo et al., Nature Medicine, vol. 5, No. 11, Nov. 1999, pp. 1277-1284.
“Flow Patterns and Spatial Distribution of Atherosclerotic Lesions in Human Coronary Arteries”, Asakura et al., McGill University Medical Clinic, Montreal General Hospital, Nov. 8, 1989, pp. 1045-1066.
“Use of fluo-3 to Measure Cytosolic Ca2+in Platelets and Neutrophils”, Merritt et al., Biochem J. (1990) 269, pp. 513-519.
“Features of Apoptotic Cells Measured by Flow Cytometry”, Darzynkiewicz et al., Cytometry 13 (1992). pp. 795-808.
“Optimal Detection of Apoptosis by Flow Cytometry Depends on Cell Morphology”, Zamai et al., Cytometry 14 (1993), pp. 891-897.
“A 50-kDa Integrin-associated Protein is Required for Integrin-Regulated Calcium Entry in Endothelial Cells”, Schwartz, et al., The Journal of Biological Chemistry, vol. 268, No. 27, Sep. 25, 1993, pp. 19931-19934.
“Structrual and Functional Aspects of RGD-Containing Cyclic Pentapeptides as Highly Potent and Selective Integrin αvβ3Antagonists”, Haubner et al., Journal of the American Chemical Society, 1996, pp. 7461-7472.

Affiliated with

Also associated with

Rating

Method for identifying active anti apoptosis compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for identifying active anti apoptosis compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for identifying active anti apoptosis compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3555793